90Y-hPAM4

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 90Y-hPAM4, covering 2021-08-16 to 2021-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of 90Y-hPAM4 at Different Doses [Phase 1, Phase 2]